India Today on MSN
Tata Sons: A legacy forged in destiny by adoption
For two centuries, the Tata name has symbolised Indian industry and philanthropy. But who exactly are Tata Sons? Who are the ...
Option Care Health Inc (OPCH) reports a robust 12% revenue increase, while navigating the impact of Stelara biosimilars and ...
Today's call will feature prepared comments by Will Lewis, Chair and Chief Executive Officer; Roger Adsett, Chief Operating Officer; and Sara Bonstein, Chief Financial Officer. After their comments, ...
Zacks Investment Research on MSN
CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Buy?
In the competitive world of small-cap biotechnology, CorMedix CRMD and Theravance Biopharma TBPH stand out as two companies ...
Kiniksa Pharmaceuticals leverages ARCALYST as it is a first-in-class FDA-approved treatment for recurrent pericarditis. Read ...
The chilling thriller from New York Times best-selling Cincinnati author Mia Sheridan releases on paperback Nov. 1.
The large molecule drug substance CDMO market is projected to grow at a CAGR of approximately 9% over the forecast period. This growth is primarily driven by the rising demand for biologics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback